The most common treatment related adverse events (TRAE) occurring in ≥ 10% of participants were nausea (52%), vomiting (39%), hypokalemia (16%), diarrhea (13%), fatigue (13%), oral pain (13%), and increased alanine aminotransferase (ALT) (13%) (Table 2). Here, GPT is linked to Hypokalemia.